Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
nafamostat
i
Other names:
FUT-175, CKD-314
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Generic mfg.
Drug class:
TMPRSS2 inhibitor, Serine protease inhibitor
Related drugs:
‹
GT0918 (3)
upamostat (0)
WX-UK1 (0)
GT0918 (3)
upamostat (0)
WX-UK1 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
ER positive
Estrogen Receptor Positive Breast Cancer
ER positive
Estrogen Receptor Positive Breast Cancer
palbociclib + nafamostat
Sensitive: D – Preclinical
palbociclib + nafamostat
Sensitive
:
D
palbociclib + nafamostat
Sensitive: D – Preclinical
palbociclib + nafamostat
Sensitive
:
D
ER positive
Estrogen Receptor Positive Breast Cancer
ER positive
Estrogen Receptor Positive Breast Cancer
nafamostat
Sensitive: D – Preclinical
nafamostat
Sensitive
:
D
nafamostat
Sensitive: D – Preclinical
nafamostat
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login